patient
Your voice guides our reserach
Every day at Tiss’You, we are inspired by the goal of creating a better tomorrow for patients in the field of musculoskeletal regenerative medicine. We are committed to achieving this goal by collaborating, aware that “together we are more effective.” As your partner, we innovate to deepen the understanding of musculoskeletal disorders; we aim to provide advanced treatments to patients worldwide.
We listen to patients, their supporters, and support communities; we listen to your stories and share your commitment.
We integrate your aspirations into our way of innovating, in our approach to research, and in the design of clinical trials, and in how we support you in the daily challenges related to your musculoskeletal conditions.
We have a common goal at Tiss’You, fueled by your resilience, and we are excited to have the opportunity to be by your side on this journey.
Our commitment to patients
Disease Areas
BONE DEFECTS AND TISSUE DAMAGE
Bone and tissue defects frequently target specific areas of the musculoskeletal system, with the hips, knees, spine, and shoulders being the most commonly affected sites. The high mechanical load borne by these regions, combined with age-related changes, makes them particularly vulnerable to damage and degeneration.
They emerge from various causes, including degenerative processes, systemic diseases, and traumatic injuries, each impacting the skeletal system in unique ways. In older adults, the most prevalent degenerative condition is osteoarthritis.
JOINT DISORDERS
Osteoarthritis, a leading cause of disability in aging individuals, is marked by the gradual degeneration of articular cartilage. Mechanical overuse, cumulative microtraumas, and chronic low-grade inflammation are primary contributors to cartilage erosion. This process triggers subchondral bone changes like osteophyte formation and inflammation of surrounding tissues.
This degenerative process is most prevalent in weight-bearing joints such as the knees, hips, and spine, but it can also affect the hands and shoulders. The loss of cartilage reduces the cushioning between bones, leading to pain and restricted movement during routine activities. Over time, bone spurs (osteophytes) can form, further exacerbating stiffness and discomfort. Patients with OA often find it difficult to walk, climb stairs, or even rise from a seated position, significantly reducing their ability to remain active and independent.
Systemic diseases such as rheumatoid arthritis, frequently afflicting hands and shoulders, introduce additional challenges, as autoimmune reactions attack synovial membranes and periarticular tissues. This chronic inflammatory response not only degrades cartilage but also weakens ligaments and erodes bone, resulting in joint deformities and severe functional impairment.
Traumatic injuries are another significant source of musculoskeletal damage. Fractures caused by falls or high-energy impacts disrupt bone continuity, while ligament tears or tendon ruptures compromise joint stability and mobility. In elderly patients, the natural decline in regenerative capacity further impairs the healing of both bone and soft tissues, prolonging recovery and increasing the likelihood of complications.
Furthermore, osteonecrosis, often linked to impaired blood supply, leads to localized bone death and collapse, particularly in the femoral head. Collectively, these defects not only compromise structural integrity but also diminish physical function and independence, creating a cascade of negative effects on patients’ overall quality of life.
The spine is another critical area, where osteoporosis predisposes vertebrae to compression fractures, leading to kyphosis (hunched posture), chronic back pain, and reduced height. These changes not only cause discomfort but also affect balance, increasing the risk of further falls and injuries. In some cases, degenerative disc disease exacerbates these issues, contributing to nerve compression and radiating pain.
INFLAMMATION AND DAMAGE TO EXTRARTICULAR TISSUES
Tendinitis and tendinopathies, while not primarily affecting joint cartilage, contribute to joint instability and pain. These conditions are commonly seen in the shoulders, elbows, knee and Achilles tendon, resulting in limited joint movement and reduced capacity to engage in repetitive or high-demand physical activities.
The functional consequences of these disorders extend far beyond the joints themselves. Pain and immobility often discourage patients from engaging in physical activity, which is crucial for maintaining muscle strength, cardiovascular health, and overall vitality. Reduced mobility can also lead to secondary complications such as weight gain, metabolic dysfunction, and increased fall risk. Furthermore, the emotional and social toll of these conditions—including frustration, loss of independence, and isolation—further diminishes quality of life.
INJECTABLE COLLAGEN TREATMENT
The intra-articular and peri-articular treatment with low molecular weight collagen peptides (short amino acid sequences) represents a modern therapeutic option to improve joint health and support the recovery of connective tissues. Collagen peptides, derived from natural collagen, are biocompatible molecules that stimulate the production of new collagen by fibroblasts and chondrocytes.
This therapy is particularly beneficial for patients suffering from degenerative joint conditions, such as osteoarthritis, or for those with tendon and ligament injuries. Injections administered directly into the joint or peri-articular areas help reduce inflammation, improve joint lubrication, and promote the restoration of the extracellular matrix.
The advantages of this treatment include rapid improvement in joint function, effective and long-lasting pain relief, and minimized risk of side effects due to the biocompatibility of the material. The use of collagen peptides can be integrated with other treatments and rehabilitation therapies to maximize clinical benefits and accelerate recovery.
Arthrys
ARTHRYS is the innovative injectable treatment developed by Tiss’You for joint regeneration and protection. ARTHRYS is composed of low molecular weight peptides from hydrolyzed collagen, formulated in an exclusive solution that acts directly on joint structures, stimulating the natural repair processes of connective tissues such as cartilage, tendons, and ligaments.
THE BONE DEFECTS IN DENTISTRY
Bone defects are also a critical concern in dentistry, particularly for older adults who often experience tooth loss and alveolar bone resorption. Conditions like periodontitis, a chronic inflammatory disease affecting the gums and supporting bone, accelerate bone loss in the jaw. This not only compromises oral health but also affects the stability of natural teeth and the success of dental implants.
The reduction in bone volume and density in the jaw can make it difficult to place dental prosthetics, requiring additional interventions such as bone grafting or the use of specialized implant systems. Furthermore, the loss of teeth and supporting bone negatively affects mastication, speech, and facial aesthetics, leading to reduced self-esteem and social interaction.
By impairing essential functions and aesthetics, these dental bone defects have a profound impact on the quality of life, particularly for elderly patients who may already be dealing with other age-related health issues. Addressing these defects effectively is vital for restoring functionality and enhancing overall well-being.
NATURAL BONE SUBSTITUTES, THE BEST WAY TO HELP BONE REGROW
Bone substitutes play a critical role in addressing defects caused by trauma, degenerative diseases, or surgical interventions. These materials, designed to support bone regeneration and provide structural stability, are used by our body as scaffold for new bony tissue formation.
The development and application of advanced biotechnology now makes it possible to obtain animal-derived biomaterials with extraordinary biocompatibility, osteoconduction, and osteopromotion properties. These bone substitutes are used to stimulate new bone formation and support bony healing process. Their natural origin and high similarity to human tissue make them one of the most effective solutions in restoring bone defects, avoiding the need to use human grafts or to undergo additional surgery for autologous bone harvesting with all the discomforts and risks this may incur.
Xenys
Using its patented EstRem tissue processing system, Tiss’You has developed XENYS, a complete line of the highest quality natural grafts, to offer patients the best possible treatment.
Pubblication
Tiss'You conducts ongoing research and clinical trials to validate the safety and efficacy of its innovative biomaterials in regenerative medicine.
Our biomaterials, e.g., bone substitutes and collagen membranes, are supported by extensive post-market surveillance studies. In compliance with Regulation 2017/745, we release annual PSUR and PMCF reports to demonstrate safety and efficacy in orthopedic, dental, and neurosurgical applications.
Arthrys, our flagship product, has been validated through PMCF white papers on conditions such as knee and hip osteoarthritis, tennis elbow, shoulder injuries, and facet syndrome. In addition, clinical investigations are being conducted in collaboration with international research institutions, with completed RCTs focusing on ligament pain (link) and hip osteoarthritis after arthroscopy (link). Ongoing RCTs are investigating knee osteoarthritis (vs. placebo) and plantar fasciitis (vs. shockwave therapy), with further studies planned.
Arhrys
Collygen
Clinical Trials
Patient Access
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum id dolor dignissim, varius arcu id, iaculis velit. Cras convallis venenatis turpis, a pretium nunc placerat at. Mauris aliquet in sem ac finibus. Donec posuere venenatis tempor. Nam pretium tortor justo, vitae porta quam cursus eget.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.